QUIDELORTHO CORP Income Tax Expense
QUIDELORTHO CORP (QDEL) reported Income Tax Expense of $11.70 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-07
- QUIDELORTHO CORP income tax expense (benefit) for the quarter ending 2026-06-28 was $11.70M, a 54.65% decline year-over-year.
- QUIDELORTHO CORP income tax expense (benefit) for the quarter ending 2026-03-29 was $12.30M, a 215.38% increase year-over-year.
- QUIDELORTHO CORP income tax expense (benefit) for the quarter ending 2025-12-28 was $18.30M, a 51.20% decline year-over-year.
- QUIDELORTHO CORP income tax expense (benefit) for the quarter ending 2025-09-28 was -$23.90M.
- QUIDELORTHO CORP income tax expense (benefit) for fiscal 2025 was $24.10M.
- QUIDELORTHO CORP income tax expense (benefit) for fiscal 2024 was -$79.50M.
- QUIDELORTHO CORP income tax expense (benefit) for fiscal 2023 was -$19.00M, a 110.15% decline from fiscal 2023.
- QUIDELORTHO CORP income tax expense (benefit) for fiscal 2023 was $187.20M, a 4.54% decline from fiscal 2022.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-28 | $11.70M 10-Q · filed 2026-08-07 | $24.00M 10-Q · filed 2026-08-07 | $42.30M derived: sum of 3 quarters · filed 2026-08-07 | $18.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | $12.30M 10-Q · filed 2026-05-06 | $30.60M derived: sum of 2 quarters · filed 2026-05-06 | $6.70M derived: sum of 3 quarters · filed 2026-05-06 | $32.50M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$5.60M derived: sum of 2 quarters · filed 2026-02-19 | $20.20M derived: sum of 3 quarters · filed 2026-08-07 | $24.10M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$23.90M 10-Q · filed 2025-11-06 | $1.90M derived: sum of 2 quarters · filed 2026-08-07 | $5.80M 10-Q · filed 2025-11-06 | $43.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | $25.80M 10-Q · filed 2026-08-07 | $29.70M 10-Q · filed 2026-08-07 | $67.20M derived: sum of 3 quarters · filed 2026-08-07 | $58.30M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $3.90M 10-Q · filed 2026-05-06 | $41.40M derived: sum of 2 quarters · filed 2026-05-06 | $32.50M derived: sum of 3 quarters · filed 2026-05-06 | $17.30M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $37.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $28.60M derived: sum of 2 quarters · filed 2026-02-19 | $13.40M derived: sum of 3 quarters · filed 2026-02-19 | -$79.50M 10-K · filed 2026-02-19 |
| 2024-09-29 | -$8.90M 10-Q · filed 2025-11-06 | -$24.10M derived: sum of 2 quarters · filed 2025-11-06 | -$117.00M 10-Q · filed 2025-11-06 | -$133.20M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$15.20M 10-Q · filed 2025-08-06 | -$108.10M 10-Q · filed 2025-08-06 | -$124.30M derived: sum of 3 quarters · filed 2026-02-19 | -$127.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$92.90M 10-Q · filed 2025-05-08 | -$109.10M derived: sum of 2 quarters · filed 2026-02-19 | -$111.90M derived: sum of 3 quarters · filed 2026-02-19 | -$123.10M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$19.00M derived: sum of 2 quarters · filed 2026-02-19 | -$30.20M derived: sum of 3 quarters · filed 2026-02-19 | -$19.00M 10-K · filed 2026-02-19 |
| 2023-10-01 | -$2.80M 10-Q · filed 2024-11-08 | -$14.00M derived: sum of 2 quarters · filed 2024-11-08 | -$2.80M 10-Q · filed 2024-11-08 | $8.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$11.20M 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $10.80M derived: sum of 3 quarters · filed 2025-02-27 | $22.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $11.20M 10-Q · filed 2024-05-09 | $22.00M derived: sum of 2 quarters · filed 2025-02-27 | $34.10M derived: sum of 3 quarters · filed 2025-02-27 | $57.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $10.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $22.90M derived: sum of 2 quarters · filed 2025-02-27 | $46.50M derived: sum of 3 quarters · filed 2025-02-27 | $187.20M 10-K · filed 2025-02-27 |
| 2022-10-02 | $12.10M 10-Q · filed 2023-11-02 | $35.70M derived: sum of 2 quarters · filed 2023-11-02 | $176.40M 10-Q · filed 2023-11-02 | $260.40M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $23.60M 10-Q · filed 2023-08-09 | $164.30M 10-Q · filed 2023-08-09 | $248.30M derived: sum of 3 quarters · filed 2024-08-01 | $314.10M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $140.70M 10-Q · filed 2023-05-04 | $224.70M derived: sum of 2 quarters · filed 2024-08-01 | $290.50M derived: sum of 3 quarters · filed 2024-08-01 | $293.10M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-01-02 | $84.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $149.80M derived: sum of 2 quarters · filed 2024-08-01 | $152.40M derived: sum of 3 quarters · filed 2024-08-01 | $196.10M 10-K/A · filed 2024-08-01 |
| 2021-10-03 | $65.80M 10-Q · filed 2022-11-04 | $68.40M derived: sum of 2 quarters · filed 2022-11-04 | $112.10M 10-Q · filed 2022-11-04 | |
| 2021-07-04 | $2.60M 10-Q · filed 2022-08-05 | $46.30M 10-Q · filed 2022-08-05 | ||
| 2021-01-03 | $230.00M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |